Press Releases - 2020-07-20

Date	Title	Company
20-Jul-2020	Coronavirus (COVID-19) Update: Daily Roundup	U.S. Food and Drug Administration
20-Jul-2020	Lyfaquin®, a first-in-class resuscitative agent for patients with excessive blood loss, to be launched in India	Pharmazz, Inc.
20-Jul-2020	Oxford Biomedica notes interim results from AstraZeneca on AZD1222 showing strong antibody and T-cell responses and acceptable safety profile	Oxford Biomedica plc
20-Jul-2020	Tiziana Life Sciences plc Director Appointment	Tiziana Life Sciences plc
20-Jul-2020	Synairgen announces positive results from trial of SNG001 in hospitalised COVID-19 patients	Synairgen plc
20-Jul-2020	Phlexglobal and Arkivum join forces to enable Trial Master File data compliance over its entire extended lifecycle	Arkivum
20-Jul-2020	Campaigners warn that the government is racing ahead with vaccine nationalism	Pfizer
20-Jul-2020	Acumentice expands senior team with Purdy appointment	Acumentice
20-Jul-2020	Polyplus-transfection launches a residual test for its transfection reagent products for ATMP sector	Polyplus-transfection
20-Jul-2020	Annual Review 2020 highlights impact on growth and productivity in the UK cell and gene therapy industry	Cell and Gene Therapy Catapult
20-Jul-2020	British Patient Capital commits $65m to SV Health Investors, to invest in life-changing biotechnology companies	SV Health Investors
20-Jul-2020	AMRYT TO ANNOUNCE Q2 RESULTS ON AUGUST 6, 2020	Amryt
20-Jul-2020	BERGENBIO ANNOUNCES FIRST PATIENT DOSED IN RECURRENT GLIOBLASTOMA INVESTIGATOR SPONSORED PHASE I/II STUDY ASSESSING SELECTIVE AXL INHIBITOR BEMCENTINIB	BerGenBio ASA
20-Jul-2020	Santhera to Join SIX Swiss Exchange Life Science Industry Indices	Santhera Pharmaceuticals
20-Jul-2020	Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2	BioNTech
20-Jul-2020	Sanifit to start new clinical development program of SNF472 in End Stage Kidney Disease patients with Peripheral Artery Disease	Sanifit
20-Jul-2020	FDA Extends Enforcement Discretion Policy for Certain Regenerative Medicine Products	U.S. Food and Drug Administration
20-Jul-2020	FDA Notifies Companies, Including Puff Bar, to Remove Flavored Disposable E-Cigarettes and Youth-Appealing E-Liquids from Market for Not Having Required Authorization	U.S. Food and Drug Administration
20-Jul-2020	IV Infusion Gravity Bags Market Size, Share, Growth Rate, Industry Analysis and Global Forecast – 2028	MARKITWIRED
20-Jul-2020	Blepharitis Treatment Market Forecast Based on Major Drivers & Trends Up to 2020	MARKITWIRED